Compared to monotherapy, the combination group had higher rates of overweight/obesity, type 2 diabetes, hypertension, and hyperlipidemia, but lower rates of ischemic heart disease, heart failure, and atrial fibrillation
This approach mirrors the initial dose escalation protocol in the Ozempic Summary of Product Characteristics (SmPC) and helps your body readjust to the medication's effects on gastric emptying and appetite
The exception would be studies measuring acute cognitive performance during active compound presence, where interruption would directly impact measured outcomes
Semaglutide GLP-1 works by increasing feelings of fullness and slowing down gastric emptying, which can lead to a significant reduction in food intake
Mol Cell Endocrinol (2015) 418 Pt 3:2404
Hamashima S, Homma T, Kobayashi S, Ishii N, Kurahashi T, Watanabe R, et al